Han F, Wang XH, Xu CZ. Clinical benefits of transarterial chemoembolization combined with tyrosine kinase and immune checkpoint inhibitors for unresectable hepatocellular carcinoma. World J Gastrointest Oncol 2024; 16(7): 3308-3320 [PMID: 39072161 DOI: 10.4251/wjgo.v16.i7.3308]
(0)
(0)
(0)
Please LOGIN to submit a new comment.